Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C009505 |
4,4'-diaminodiphenylmethane |
4,4'-diaminodiphenylmethane results in increased expression of PSCA mRNA | increases expression | 18648102
|
C501474 |
4-OH-2',3,3',4',5'-pentachlorobiphenyl |
4-OH-2',3,3',4',5'-pentachlorobiphenyl inhibits the reaction [Triiodothyronine results in increased expression of PSCA mRNA] | decreases reaction|increases expression | 14761676
|
C109238 |
acyline |
acyline results in decreased expression of PSCA mRNA | decreases expression | 17510436
|
C501521 |
Akt-I-1,2 compound |
Akt-I-1,2 compound inhibits the reaction [Flurbiprofen results in increased expression of PSCA protein] | decreases reaction|increases expression | 16949054
|
D000638 |
Amiodarone |
Amiodarone results in decreased expression of PSCA mRNA | decreases expression | 17991464
|
D000728 |
Androgens |
Androgens affects the expression of PSCA protein | affects expression | 16015594
|
D047310 |
Apigenin |
Apigenin results in decreased expression of PSCA mRNA | decreases expression | 18331776
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of PSCA mRNA | increases expression | 19150397
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in increased expression of PSCA mRNA | increases expression | 14729362 15003993
|
C043561 |
chrysin |
chrysin results in decreased expression of PSCA mRNA | decreases expression | 18331776
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of PSCA mRNA | decreases expression | 20106945
|
D004958 |
Estradiol |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of PSCA mRNA | affects cotreatment|increases expression | 19619570
|
D004958 |
Estradiol |
Estradiol results in decreased expression of PSCA mRNA | decreases expression | 19619570
|
D005480 |
Flurbiprofen |
AKT1 protein affects the reaction [Flurbiprofen results in increased expression of PSCA mRNA] | affects reaction|increases expression | 16949054
|
D005480 |
Flurbiprofen |
Akt-I-1,2 compound inhibits the reaction [Flurbiprofen results in increased expression of PSCA protein] | decreases reaction|increases expression | 16949054
|
D005480 |
Flurbiprofen |
Flurbiprofen results in increased expression of PSCA mRNA | increases expression | 16949054
|
D005480 |
Flurbiprofen |
[Flurbiprofen results in increased phosphorylation of and results in increased activity of PSCA protein] which results in increased expression of AKT1 protein | increases activity|increases expression|increases phosphorylation | 16949054
|
D005480 |
Flurbiprofen |
HRAS protein affects the reaction [Flurbiprofen results in increased expression of PSCA mRNA] | affects reaction|increases expression | 16949054
|
C006552 |
kaempferol |
kaempferol results in decreased expression of PSCA mRNA | decreases expression | 18331776
|
D047311 |
Luteolin |
Luteolin results in decreased expression of PSCA mRNA | decreases expression | 19397994 18331776
|
C040015 |
myricetin |
myricetin results in decreased expression of PSCA mRNA | decreases expression | 18331776
|
D011078 |
Polychlorinated Biphenyls |
Polychlorinated Biphenyls inhibits the reaction [Triiodothyronine results in increased expression of PSCA mRNA] | decreases reaction|increases expression | 14761676
|
D011794 |
Quercetin |
Quercetin results in decreased expression of PSCA mRNA | decreases expression | 18331776
|
C009277 |
sodium arsenate |
sodium arsenate results in decreased expression of PSCA mRNA | decreases expression | 12727804
|
C017947 |
sodium arsenite |
sodium arsenite results in decreased expression of PSCA mRNA | decreases expression | 12727804
|
C025463 |
sulindac sulfone |
sulindac sulfone results in increased expression of PSCA mRNA | increases expression | 16949054
|
D014284 |
Triiodothyronine |
4-OH-2',3,3',4',5'-pentachlorobiphenyl inhibits the reaction [Triiodothyronine results in increased expression of PSCA mRNA] | decreases reaction|increases expression | 14761676
|
D014284 |
Triiodothyronine |
Polychlorinated Biphenyls inhibits the reaction [Triiodothyronine results in increased expression of PSCA mRNA] | decreases reaction|increases expression | 14761676
|
D014284 |
Triiodothyronine |
Tetrachlorodibenzodioxin promotes the reaction [Triiodothyronine results in increased expression of PSCA mRNA] | increases expression|increases reaction | 14761676
|
D014284 |
Triiodothyronine |
Tetrachlorodibenzodioxin promotes the reaction [Triiodothyronine results in increased expression of PSCA protein] | increases expression|increases reaction | 14761676
|
D014284 |
Triiodothyronine |
Triiodothyronine results in increased expression of PSCA mRNA | increases expression | 14761676
|
D014284 |
Triiodothyronine |
Triiodothyronine results in increased expression of PSCA protein | increases expression | 14761676
|
D013749 |
Tetrachlorodibenzodioxin |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of PSCA mRNA | affects cotreatment|increases expression | 19619570
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin promotes the reaction [Triiodothyronine results in increased expression of PSCA mRNA] | increases expression|increases reaction | 14761676
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin promotes the reaction [Triiodothyronine results in increased expression of PSCA protein] | increases expression|increases reaction | 14761676
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of PSCA mRNA | decreases expression | 19619570 20106945
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of PSCA mRNA | increases expression | 17035482
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.70 | 14514962 15322242 11752688 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
2.06 | 11473722 |
MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
2.67 | 3712494 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.23 | 16835633 |
MESH:D011125 |
Adenomatous Polyposis Coli |
|
Flurbiprofen |
10.13 | 10680582 |
MESH:D011125 |
Adenomatous Polyposis Coli |
|
sulindac sulfone |
10.13 | 16150858 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.55 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.75 | 16712894 17306315 |
MESH:D000544 |
Alzheimer Disease |
|
Androgens |
3.58 | 17917157 17182789 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.81 | 11748828 |
MESH:D000743 |
Anemia, Hemolytic |
|
Quercetin |
4.10 | 17084956 |
MESH:D001145 |
Arrhythmias, Cardiac |
|
Amiodarone |
3.67 | 18057881 18218290 20041841 |
MESH:D001260 |
Ataxia Telangiectasia |
|
Quercetin |
4.82 | 15336622 |
MESH:D001281 |
Atrial Fibrillation |
|
Amiodarone |
3.79 | 18651412 19698954 |
MESH:D001327 |
Autoimmune Diseases |
|
Quercetin |
4.26 | 19761891 |
MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
4.87 | 1440618 11289319 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Amiodarone |
8.58 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
8.58 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.64 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.67 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
Androgens |
2.91 | 17018787 |
MESH:D001943 |
Breast Neoplasms |
|
Apigenin |
2.91 | 17132221 16541309 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
2.91 | 17289903 18497071 12948864 14630087 17018787 19861407 17261762 16675129 |
MESH:D001943 |
Breast Neoplasms |
|
kaempferol |
2.91 | 16756079 |
MESH:D001943 |
Breast Neoplasms |
|
Quercetin |
2.91 | 18628248 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.91 | 20435547 |
MESH:D002105 |
Cadmium Poisoning |
|
Quercetin |
5.39 | 16962696 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.31 | 16111702 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.68 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
6.39 | 3581430 7296757 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
6.39 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Quercetin |
6.39 | 19519916 12508355 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
6.39 | 15276417 17306315 16507464 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
sulindac sulfone |
4.03 | 18758305 |
MESH:D021441 |
Carcinoma, Pancreatic Ductal |
|
Quercetin |
4.80 | 17234771 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
2.61 | 7296757 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
2.34 | 18572023 |
MESH:D006332 |
Cardiomegaly |
|
Quercetin |
6.53 | 19794523 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
6.53 | 16120746 18850075 18670907 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Amiodarone |
2.84 | 19225199 15710769 |
MESH:D002318 |
Cardiovascular Diseases |
|
kaempferol |
4.29 | 16756079 |
MESH:D002341 |
Carotid Artery Thrombosis |
|
Amiodarone |
4.93 | 18974383 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
19.98 | 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
19.98 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
19.98 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
19.98 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
19.98 | 19524636 20056578 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.03 | 16835633 |
MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
7.50 | 9022650 19486331 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
7.50 | 19486331 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.04 | 15340226 8697196 16354765 12621046 15668235 |
MESH:D003110 |
Colonic Neoplasms |
|
Quercetin |
2.40 | 15741050 19056647 11134977 17148506 16640504 19440933 17191121 |
MESH:D015179 |
Colorectal Neoplasms |
|
Polychlorinated Biphenyls |
3.71 | 15531428 |
MESH:D015179 |
Colorectal Neoplasms |
|
Quercetin |
3.71 | 18852136 18095365 |
MESH:D015179 |
Colorectal Neoplasms |
|
sulindac sulfone |
3.71 | 10416599 11197048 10666051 18059344 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.93 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
sodium arsenate |
2.73 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.73 | 10048152 20055451 15322242 |
MESH:D016638 |
Critical Illness |
|
Androgens |
5.91 | 16670151 |
MESH:D003704 |
Dementia |
|
Polychlorinated Biphenyls |
4.56 | 16140633 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
2.66 | 11906362 8156756 12868966 18759878 11298694 8970840 2524372 14531868 |
MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
3.35 | 2952479 3621924 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Quercetin |
3.61 | 19496084 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.63 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
3.28 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
8.65 | 18289764 9328219 6482804 1440618 11289319 16192314 9653073 7440962 18692083 8291058 18648102 9022650 6679447 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Amiodarone |
8.65 | 18218290 15265979 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
sodium arsenate |
8.65 | 18186108 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
8.65 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.65 | 11462148 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.24 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.75 | 18230668 15322242 16714409 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
2.88 | 18566989 11473722 19148513 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.89 | 10568697 9294722 |
MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
4.25 | 3581430 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
4.25 | 20426865 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.90 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Amiodarone |
7.38 | 14986274 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
7.38 | 19224547 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.31 | 11858732 |
MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
4.87 | 6705139 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
13.90 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Quercetin |
13.90 | 19474275 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
13.90 | 20067830 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.53 | 16452187 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.07 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
myricetin |
7.54 | 19804834 |
MESH:D005909 |
Glioblastoma |
|
Quercetin |
7.54 | 19804834 |
MESH:D005910 |
Glioma |
|
Quercetin |
3.00 | 17643826 |
MESH:D018149 |
Glucose Intolerance |
|
sodium arsenate |
4.94 | 19446573 |
MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
3.89 | 7505956 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.44 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.25 | 11294989 10048152 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.27 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.20 | 11000095 |
MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
3.37 | 6705139 |
MESH:D006529 |
Hepatomegaly |
|
Amiodarone |
8.04 | 15265979 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
8.04 | 16120746 15340226 12621046 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.88 | 15709030 |
MESH:D006628 |
Hirsutism |
|
Androgens |
5.93 | 16914592 17019078 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
3.03 | 12676792 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.60 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.89 | 16354765 15340226 16959395 8697196 18606429 |
MESH:D017588 |
Hyperandrogenism |
|
Androgens |
5.58 | 17019078 |
MESH:D006937 |
Hypercholesterolemia |
|
Amiodarone |
3.73 | 9751232 8137927 |
MESH:D006943 |
Hyperglycemia |
|
kaempferol |
9.46 | 18262572 |
MESH:D006943 |
Hyperglycemia |
|
Quercetin |
9.46 | 18262572 11834736 |
MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
3.79 | 15034207 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
8.24 | 10903974 |
MESH:D006973 |
Hypertension |
|
Quercetin |
8.24 | 18356687 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
8.24 | 18850075 18670907 |
MESH:D007037 |
Hypothyroidism |
|
Amiodarone |
4.36 | 17991464 18020914 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
2.89 | 12646999 15346721 |
MESH:D007249 |
Inflammation |
|
Flurbiprofen |
5.15 | 11099482 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
5.15 | 12200463 12878042 |
MESH:D007251 |
Influenza, Human |
|
Quercetin |
4.36 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
2.87 | 16393666 16627594 |
MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
4.87 | 9022650 8074119 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.20 | 16580747 |
MESH:D007627 |
Keloid |
|
Quercetin |
4.80 | 17086741 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.29 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
13.75 | 8314463 10903974 18776723 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
13.75 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
Quercetin |
13.75 | 16962696 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
13.75 | 20008137 |
MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
11.64 | 6582329 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
11.64 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
11.64 | 15610895 |
MESH:D007938 |
Leukemia |
|
kaempferol |
6.71 | 17468513 |
MESH:D007938 |
Leukemia |
|
Quercetin |
6.71 | 17468513 |
MESH:D008039 |
Linitis Plastica |
marker/mechanism |
|
| 18488030 |
MESH:D008064 |
Lipidoses |
|
Amiodarone |
3.40 | 15342952 17567588 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
3.10 | 15034207 9327722 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
3.39 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Quercetin |
3.39 | 12741479 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.39 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
Quercetin |
7.14 | 18980244 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
7.14 | 15276417 16712894 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
7.14 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
13.40 | 3712494 598648 6587162 1399818 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Polychlorinated Biphenyls |
13.40 | 1423854 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Quercetin |
13.40 | 19519916 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
13.40 | 12151625 |
MESH:D008133 |
Long QT Syndrome |
|
Amiodarone |
3.46 | 11989578 15350150 17391786 |
MESH:D008171 |
Lung Diseases |
|
Amiodarone |
7.18 | 12587719 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
7.18 | 19095001 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Amiodarone |
4.33 | 18516814 |
MESH:D008175 |
Lung Neoplasms |
|
Quercetin |
3.35 | 16280456 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
3.35 | 15276417 17077188 16712894 19931552 17306315 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
3.35 | 11884234 19555203 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
2.47 | 11807958 17203775 16891317 11408345 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.33 | 19453300 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
2.01 | 16487513 19082730 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.64 | 16801185 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
sodium arsenate |
4.72 | 18186108 |
MESH:D009181 |
Mycoses |
|
Amiodarone |
4.75 | 12754197 17974566 |
MESH:D009203 |
Myocardial Infarction |
|
Quercetin |
2.93 | 19595682 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.90 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
8.17 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Quercetin |
8.17 | 19207477 |
MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
2.41 | 3581430 |
MESH:D009369 |
Neoplasms |
|
Quercetin |
5.01 | 15185748 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
5.01 | 11559025 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.52 | 20056578 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.58 | 17289903 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.29 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.15 | 18481113 19348381 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
8.97 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
8.97 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
11.68 | 6679447 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenate |
11.68 | 10525206 18186108 11749123 19446573 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
11.68 | 12854658 |
MESH:D020078 |
Neurogenic Inflammation |
|
Quercetin |
4.22 | 17929310 |
MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
3.29 | 4026338 6482804 |
MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
4.87 | 3988306 |
MESH:D010024 |
Osteoporosis |
|
kaempferol |
4.26 | 16756079 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Quercetin |
4.08 | 19495926 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
10.98 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Luteolin |
10.98 | 19005980 |
MESH:D010051 |
Ovarian Neoplasms |
|
Quercetin |
10.98 | 19005980 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
10.98 | 15276417 17306315 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Quercetin |
2.80 | 16965848 |
MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
3.33 | 7296757 |
MESH:D010300 |
Parkinson Disease |
|
Polychlorinated Biphenyls |
3.34 | 16702228 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.10 | 12520081 |
MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
4.32 | 6228378 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.41 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
8.67 | 12371664 |
MESH:D011230 |
Precancerous Conditions |
|
Quercetin |
8.67 | 19056647 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.04 | 11896295 11118676 11399792 11222880 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.75 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
marker/mechanism |
|
| 16015594 |
MESH:D011471 |
Prostatic Neoplasms |
|
Androgens |
2.43 | 15389811 16998812 17909013 |
MESH:D011471 |
Prostatic Neoplasms |
|
Apigenin |
2.43 | 17132221 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.43 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Flurbiprofen |
2.43 | 17409433 |
MESH:D011471 |
Prostatic Neoplasms |
|
Polychlorinated Biphenyls |
2.43 | 15721890 |
MESH:D011471 |
Prostatic Neoplasms |
|
Quercetin |
2.43 | 14715546 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
2.43 | 16039940 |
MESH:D011471 |
Prostatic Neoplasms |
|
sulindac sulfone |
2.43 | 15570007 17908994 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.18 | 16882103 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Amiodarone |
2.80 | 11597910 12832656 12490602 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.69 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
3.26 | 3692021 |
MESH:D012554 |
Schistosomiasis japonica |
|
Quercetin |
5.39 | 16862918 |
OMIM:609620 |
SHORT QT SYNDROME 1 |
|
Amiodarone |
4.93 | 18724381 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
9.03 | 18572023 19524636 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
9.03 | 8532709 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
9.03 | 16192470 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.68 | 12854658 |
MESH:D013274 |
Stomach Neoplasms |
marker/mechanism |
|
| 18488030 |
MESH:D013276 |
Stomach Ulcer |
|
Amiodarone |
3.18 | 18087811 |
MESH:D013610 |
Tachycardia |
|
Amiodarone |
4.14 | 11238279 |
MESH:D017180 |
Tachycardia, Ventricular |
|
Amiodarone |
4.04 | 19225199 |
MESH:D013959 |
Thyroid Diseases |
|
Amiodarone |
11.55 | 19731979 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
11.55 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
2.77 | 6587162 6582329 7505956 3712494 1399818 |
MESH:D013971 |
Thyrotoxicosis |
|
Amiodarone |
4.71 | 19584973 18020914 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.53 | 19048282 |
MESH:D016171 |
Torsades de Pointes |
|
Amiodarone |
4.04 | 17467628 11989578 |
MESH:D001749 |
Urinary Bladder Neoplasms |
marker/mechanism |
|
| 19648920 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
8.03 | 8074119 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Quercetin |
8.03 | 16720314 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
8.03 | 16712894 17306315 11723127 16452187 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
3.63 | 11813266 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.83 | 1336536 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.27 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.44 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.10 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.29 | 17120751 |